Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Pharmacokinetic / Pharmacodynamic (PK/PD) Simulations Guide Selection of the Dose for Administration of Efgartigimod Subcutaneously in a Phase 3 Clinical Trial in Patients with Primary Immune Thrombocytopenia

Waleed Ghanima, Vickie McDonald, Shivi Jain, Monica Carpenedo, Esther N. Oliva, Anna Hultberg, Domenica Gandini, Erik Hofman, Tonke Van Bragt, Wim Parys, Benjamin van Hoorick, Yoshitaka Miyakawa, Catherine M. Broome

Blood (2021) 138 (Supplement 1): 3165.

https://doi.org/10.1182/blood-2021-153261

Published: 2021

Journal Articles

The Real-World Incidence of Relapse in Acute Myeloid Leukemia (AML): A Systematic Literature Review (SLR)

Esther N. Oliva, Jacob Franek, Dipen Patel, Omer Zaidi, Salem Abi Nehme, Antonio M. Almeida

Blood (2018) 132 (Supplement 1): 5188.

https://doi.org/10.1182/blood-2018-99-111839

Published: 2018

Journal Articles

A Phase 3 Randomized Placebo (PBO)-Controlled Double-Blind Trial of Darbepoetin Alfa in the Treatment of Anemia in Patients with Low or Intermediate-1 (Int-1) Risk Myelodysplastic Syndromes (MDS)

Uwe Platzbecker, MD, Argiris Symeonidis, Esther N. Oliva, Jeroen S. Goede, Michel Delforge, Jiri Mayer, Borhane Slama, Sejal Badre, Eduard Gasal, Bhakti Mehta, Janet Franklin

Blood (2016) 128 (22): 2010.

https://doi.org/10.1182/blood.V128.22.2010.2010

Published: 2016

Journal Articles

Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1

Jing Fang, Garrett Rhyasen, Lyndsey Bolanos, Christopher Rasch, Melinda Varney, Mark Wunderlich, Susumu Goyama, Gerrit Jansen, Jacqueline Cloos, Carmela Rigolino, Agostino Cortelezzi, James C. Mulloy, Esther N. Oliva, Maria Cuzzola, Daniel T. Starczynowski

Blood (2012) 120 (4): 858–867.

https://doi.org/10.1182/blood-2012-02-407999

Published: 2012

Includes: Supplemental data

Journal Articles

Changes in Gene Expression Profiles during Treatment with Erythropoetic Growth Factors in Myelodysplastic Syndromes.

Esther N. Oliva, MD, Margherita Comis, MD, Pasquale Iacopino, MD, Mariella Cuzzola, BSc, Roberto Latagliata, MD, Marco Danova, MD, Bianca Rovati, MD, Giovanni Spampinato, Giuliana Alimena, MD, Ida Carmosino, MD, Massimo Breccia, MD, Francesco Nobile, MD

Blood (2007) 110 (11): 4609.

https://doi.org/10.1182/blood.V110.11.4609.4609

Published: 2007

Journal Articles

Darbepoetin for the Treatment of Anemia of Myelodysplastic Syndromes: Efficacy and Improvements in Quality of Life.

Esther N. Oliva, MD, Roberto Latagliata, MD, Marco Danova, MD, Iolanda Vincelli, MD, Bianca Rovati, MD, Francesca Ronco, MD, Ida Carmosino, MD, Giorgina Specchia, MD, Massimo Breccia, MD, Stefana Impera, MD, Imma Attolico, MD, Francesco Nobile, MD

Blood (2006) 108 (11): 2667.

https://doi.org/10.1182/blood.V108.11.2667.2667

Published: 2006

Journal Articles

Quality of Life in Elderly Patients with Acute Myeloid Leukemia.

Esther N. Oliva, MD, Roberto Latagliata, MD, Iolanda Vincelli, MD, Giorgina Specchia, MD, Francesca Ronco, MD, Vincenzo Liso, MD, Stefana Impera, MD, Caterina Alati, MD, Alessandra Quota, MD, Giuliana Alimena, MD, Massimo Breccia, MD, Ida Carmosino, MD, Francesco Fortugno, MD, Francesco Nobile, MD

Blood (2006) 108 (11): 3320.

https://doi.org/10.1182/blood.V108.11.3320.3320

Published: 2006

Journal Articles

Risk Factors for Cardiovascular Events in Myeloproliferative Syndromes.

Iolanda Vincelli, MD, Esther N. Oliva, MD, Roberto Latagliata, MD, Giorgina Specchia, MD, Giuliana Alimena, MD, Massimo Breccia, MD, Caterina Alati, MD, Ida Carmosino, MD, Grazia Iaria, MD, Antonio Marino, MD, Natale Ranieri, MD, Vincenzo Liso, MD, Francesca Ronco, MD, Bruno Martino, MD, Francesco Nobile, MD

Blood (2006) 108 (11): 3595.

https://doi.org/10.1182/blood.V108.11.3595.3595

Published: 2006

Journal Articles

Treatment of Anemia of Myelodysplastic Syndromes and Improvements in Cardiac Geometry.

Esther N. Oliva, MD, Frank Benedetto, MD, Giorgina Specchia, MD, Iolanda Vincelli, MD, Paolo Colonna, MD, Vincenzo Liso, MD, Francesco Fortugno, MD, Francesco Nobile, MD

Blood (2006) 108 (11): 4837.

https://doi.org/10.1182/blood.V108.11.4837.4837

Published: 2006

Journal Articles

Quality of Life in Elderly Patients with Acute Myeloid Leukemia.

Esther N. Oliva, MD, Francesca Ronco, MD, Stefana Impera, MD, Iolanda Vincelli, MD, Caterina Alati, MD, Borislav D. Dimitrov, MD, MSc, Rosario Giustolisi, MD, Francesco Nobile, MD

Blood (2004) 104 (11): 3136.

https://doi.org/10.1182/blood.V104.11.3136.3136

Published: 2004

Journal Articles

Darbepoetin Efficacy in Myelodysplastic Syndrome.

Esther N. Oliva, MD, Francesca Ronco, MD, Marco Danova, MD, Bianca Rovati, MD, Borislav D. Dimitrov, MD, MSc, Iolanda Vincelli, MD, Caterina Alati, MD, Francesco Nobile, MD

Blood (2004) 104 (11): 4704.

https://doi.org/10.1182/blood.V104.11.4704.4704

Published: 2004

Journal Articles

Hemoglobin Level Threshold in Myelodysplastic Syndrome: Cardiac Hypertrophy and Quality of Life.

Esther N. Oliva, MD, Borislav D. Dimitrov, MD, MSc, Arianna D’Angelo, MD, Frank Benedetto, MD, Francesco Nobile, MD

Blood (2004) 104 (11): 1444.

https://doi.org/10.1182/blood.V104.11.1444.1444

Published: 2004

NARROW

Pharmacokinetic / Pharmacodynamic (PK/PD) Simulations Guide Selection of the Dose for Administration of Efgartigimod Subcutaneously in a Phase 3 Clinical Trial in Patients with Primary Immune Thrombocytopenia

The Real-World Incidence of Relapse in Acute Myeloid Leukemia (AML): A Systematic Literature Review (SLR)

A Phase 3 Randomized Placebo (PBO)-Controlled Double-Blind Trial of Darbepoetin Alfa in the Treatment of Anemia in Patients with Low or Intermediate-1 (Int-1) Risk Myelodysplastic Syndromes (MDS)

Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1

Changes in Gene Expression Profiles during Treatment with Erythropoetic Growth Factors in Myelodysplastic Syndromes.

Darbepoetin for the Treatment of Anemia of Myelodysplastic Syndromes: Efficacy and Improvements in Quality of Life.

Quality of Life in Elderly Patients with Acute Myeloid Leukemia.

Risk Factors for Cardiovascular Events in Myeloproliferative Syndromes.

Treatment of Anemia of Myelodysplastic Syndromes and Improvements in Cardiac Geometry.

Quality of Life in Elderly Patients with Acute Myeloid Leukemia.

Darbepoetin Efficacy in Myelodysplastic Syndrome.

Hemoglobin Level Threshold in Myelodysplastic Syndrome: Cardiac Hypertrophy and Quality of Life.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only